Need $8,500? Invest in These 8 Dividend Stocks
24/7 Wall Street Insights A 4,000 person Jenius Bank survey revealed that inflation has put 50% of them in dire financial straits. Lending Tree found that one-third of American households can’t pay…
Headquartered in Newton, MA Fiscal year ends December NASDAQ: DHC dhcreit.com
Diversified Healthcare Trust (DHC) is a real estate investment trust focused on owning healthcare properties throughout the United States. As of June 30, 2026, DHC's approximately $6.3 billion portfolio included 285 properties across 33 states and Washington, D.C., comprising 23,797 senior living units and approximately 5.6 million square feet of medical office and life science properties occupied by approximately 250 tenants. The portfolio is anchored by three segments: a Senior Housing Operating Portfolio (SHOP) of 199 communities managed by third-party operators including Discovery Senior Living, Sinceri Senior Living, and Stellar Senior Living; a Medical Office and Life Science Portfolio of 67 properties leased to healthcare providers, biotech laboratories, and related tenants; and an All Other segment of 19 triple net leased wellness centers and senior living communities. DHC also holds interests in unconsolidated joint ventures including an ownership stake in a 1.1 million square foot life science property in Boston and a portfolio of 10 medical office and life science properties. The company is externally managed by The RMR Group (Nasdaq: RMR), an alternative asset management company with over $37 billion in assets under management. DHC trades on Nasdaq and its senior unsecured notes also trade under the symbols DHCNI and DHCNL. Updated
24/7 Wall Street Insights A 4,000 person Jenius Bank survey revealed that inflation has put 50% of them in dire financial straits. Lending Tree found that one-third of American households can’t pay…
Diversified Healthcare Trust (DHC) is a real estate investment trust focused on owning healthcare properties throughout the United States.
The Wall Street consensus 12-month price target for DHC is $10.15.